Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 83 (3) , 453-455
- https://doi.org/10.1016/s0002-9149(98)00886-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Transesophageal Echocardiographic Correlates of Thromboembolism in High-Risk Patients with Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 1998
- Mobile Aortic Atheroma and Systemic Emboli: Efficacy of Anticoagulation and Influence of Plaque Morphology on Recurrent StrokeJournal of the American College of Cardiology, 1998
- Pathologic Correlates of Aortic Plaques, Thrombi and Mobile “Aortic Debris” Imaged In Vivo With Transesophageal EchocardiographyJournal of the American College of Cardiology, 1997
- Mobile Thromboses of the Aortic Arch Without Aortic DebrisCirculation, 1997
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996
- Atherosclerotic Disease of the Aortic Arch as a Risk Factor for Recurrent Ischemic StrokeNew England Journal of Medicine, 1996
- Natural history of severe atheromatous disease of the thoracic aorta: A transesophageal echocardiographic studyJournal of the American College of Cardiology, 1996
- Mobile thrombi in atherosclerotic lesions of the thoracic aorta: The diagnostic impact of transesophageal echocardiographyAmerican Heart Journal, 1993